| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/16/2004 | US20040253712 Pathogenic protein for use in screening and iidentifying agents which prevent bacterial infection; bactericides; immunoassays |
| 12/16/2004 | US20040253711 Mycobacterial genes down-regulated during latency |
| 12/16/2004 | US20040253710 Transgenic escherichia for which express bacterial surface protein for use in generation of vaccine which prevents coliform bacterial infection; antidiarrhea agents |
| 12/16/2004 | US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases |
| 12/16/2004 | US20040253708 Apo-2 ligand |
| 12/16/2004 | US20040253706 Substrates and assays for beta-secretase |
| 12/16/2004 | US20040253699 Insect inhibitory lipid acyl hydrolases |
| 12/16/2004 | US20040253689 Mutants of human insulin-like growth factor binding protein-3 (igfbp-3) and uses thereof |
| 12/16/2004 | US20040253687 Using multicompartment apparatus and affinity chromatography to isolate/purify preferential protein from cell solutions |
| 12/16/2004 | US20040253686 Novel human kunitz-type inhibitors and methods relating thereto |
| 12/16/2004 | US20040253684 Nucleotide sequences coding mambrane associated guanylate kinase for use in treatment and prevention of nervous system, blood, sleep and behavioral disorders |
| 12/16/2004 | US20040253683 Cryptopain compositions for prophylaxis, treatment, diagnosis and detection of cryptosporidium species |
| 12/16/2004 | US20040253682 Immunloglobulin prostaglandin inhibitor for use in the treatment and prevention of arthritic and inflammatory bowel disorders |
| 12/16/2004 | US20040253679 Immunomodulatory agent which binds endothelial growth factor for use as therapeutic agent in treatment of tumors; tissue target therapy |
| 12/16/2004 | US20040253678 Novel collagen production method |
| 12/16/2004 | US20040253677 mTOR kinase-associated proteins |
| 12/16/2004 | US20040253675 Method for GPCR assay with a coexpressed Galpha protein |
| 12/16/2004 | US20040253674 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (LIR) |
| 12/16/2004 | US20040253673 Recombinant botulinum toxins with a soluble C-terminal portion |
| 12/16/2004 | US20040253672 Expression vector comprising nucleotide sequences coding signal peptide modified protein for use in identifying modulator for treatment and prevention of muscular and respiratory disorders |
| 12/16/2004 | US20040253671 Isolating hexose oxidase for use as tool in enhancement of nutrient quality of animal feeeds |
| 12/16/2004 | US20040253668 Expression vector comprising nucleotide sequences coding membrane protein for use identifying modulators for treatment of cell proliferative, respiratory, nervous system, autoimmune and inflammatory disorders |
| 12/16/2004 | US20040253667 Expression vector comprising nuclelotide sequences coding membrane protein for use in identifying modulator for treatment of cell proliferative, nervous system and inflammatory diseases |
| 12/16/2004 | US20040253666 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 12/16/2004 | US20040253654 Streptococcus uberis adhesion molecule |
| 12/16/2004 | US20040253647 Evaluating modulators effectiveness as treatment for alzheimer's via quantifying amyloid precursor protein peptide cleavage products present after exposure agonist/antagonist |
| 12/16/2004 | US20040253644 Rheumatoid arthritis autoantigen polypeptides |
| 12/16/2004 | US20040253643 Using ratio of neurofibrillary tangle to amyloid beta protein in cerebrospinal fluid as diagnostic indicator of nervous system disorders; immunodiagnostics |
| 12/16/2004 | US20040253630 Using macrophage surface receptor genes as diagnostic and therapeutic tools in treatment of inflammatory and respiratory system disorders |
| 12/16/2004 | US20040253629 Expression vector comprising nucleotide sequences coding bcl-2-related ovarian killer (BOK) for use as diagnostic/investigative tool in elucidating mechanisms of apoptopsis, specifically in reproduction; antiproliferative agents |
| 12/16/2004 | US20040253623 Nucleic acid binding proteins |
| 12/16/2004 | US20040253618 Expression vector comprising nucleotide sequences coding tumor associated membrane protein for use in diagnosis, prevention and treatment of cell proliferative disorders of urogenital systems |
| 12/16/2004 | US20040253615 NOD nucleic acids and polypeptides |
| 12/16/2004 | US20040253612 Selection of proteins using RNA-protein fusions |
| 12/16/2004 | US20040253611 Immunologically active proteins from borrelia burgdorferi |
| 12/16/2004 | US20040253610 Expression vector comprising nucleotide sequences coding tumor necrosis factor receptor protein (TWEAK) for use in identifying modulators for treatment of inflammatory, cardiovacullar, vision and cancer disorders |
| 12/16/2004 | US20040253608 Compounds with anti-KS and anti-HIV activity |
| 12/16/2004 | US20040253605 Expression vector comprising nucleotide sequences coding aggrecanase for use in diagnosis, prevention and treatment of cell proliferative disorders |
| 12/16/2004 | US20040253602 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 12/16/2004 | US20040253601 Methods for overexpression of high molecular weight form of mannose binding lectin (MBL) and a specific formulation for active treatment for systemic infection with microorganism |
| 12/16/2004 | US20040253599 Novel protein, its dna and use thereof |
| 12/16/2004 | US20040253598 Nucleic and amino acid sequences; autoimmune/inflammatory disorders, cancer; expression vectors, host cells, antibodies, agonists, antagonists. transgenic organisms |
| 12/16/2004 | US20040253597 Sodium dependent dicarboxylate transport protein for use in identifying modulators for prevention/treatment of hepatic, prostate, splenic, renal diseases, metabolic, circulatory, cancer and aging disorders |
| 12/16/2004 | US20040253595 P53-dependent apoptosis-inducing protein and method of screening for apoptosis regulator |
| 12/16/2004 | US20040253592 Polypeptide factor from a thermophilic eubacterial species and use thereof in the production of functional, heterologous proteins in an expression host |
| 12/16/2004 | US20040253587 Antagonists of interleukin-15 |
| 12/16/2004 | US20040253586 Plastid transformation |
| 12/16/2004 | US20040253581 Transgenic animals expressing transdominant negative retroviral nucleic acids and proteins |
| 12/16/2004 | US20040253580 Nucleotide sequences coding viral protein for use in treatment and prevention of viral disease in fish; veterinary medicine |
| 12/16/2004 | US20040253577 Polypeptide comprising helicase activity for use as tool in design of drugs for treatment and prevention of viral infection; viricides |
| 12/16/2004 | US20040253303 Biodrugs contains carrier capable of introducing the isolated DNA molecule into a mammalian cell; ANTITUMOR AGENTS, VIRICIDES, BACTERICIDES; GENE EXPRESSION BY IMMUNOCOMPETENT CELLS; AUTOIMMUNED DISEASE TREATMENT; SIDE EFFECT REDUCTION |
| 12/16/2004 | US20040253273 Recombinant influenza viruses expressing tumor-associated antigens as antitumor agents |
| 12/16/2004 | US20040253271 Live attenuated viral vaccines for Eastern equine encephalitis virus |
| 12/16/2004 | US20040253270 Nucleic acid encoding infectious, nonpathogenic porcine circovirus type-1(PCV1), which contains immunogenic open reading frame gene of pathogenic PCV2 in place of an ORF gene of PCV1 nucleic acid molecule; means of protecting pigs against viral infection or postweaning multisystemic wasting syndrome |
| 12/16/2004 | US20040253250 Compositions and methods for regulating lymphocyte activation |
| 12/16/2004 | US20040253248 Substance P-saporin (SP-SAP) conjugates and methods of use thereof |
| 12/16/2004 | US20040253247 Conjugate comprising a peptide having an engineered amino acid sequence capable of binding a plasma protein, said peptide conjugated to the therapeutic or diagnostic substance, wherein elimination half time of conjugate exceeds that of unconjugated therapeutic or diagnostic substance; peptide ligands |
| 12/16/2004 | US20040253246 isolated nucleic acid (DNA, cDNA, or RNA); an expression vector; host cell expressing the vector; a polypeptide; detecting hematogenous micrometastic tumor cells; determining prostate cancer progression |
| 12/16/2004 | US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease |
| 12/16/2004 | US20040253242 immunoglobulins or fragments comprising complementarity determining regions (CDR) having segments replaced with human brain natriuretic peptides, glucagon-like peptides, exendins, glucagons, pituitary adenylate cyclase-activating polypeptides and/or mimetics; immunotherapy |
| 12/16/2004 | US20040253240 immunogens used to induce immune response against specific epitopes of apolipoproteins; prophylaxis of atherosclerosis; immunotherapy |
| 12/16/2004 | US20040253239 nucleotide sequences that code angiogenic factor antagonists and vascular endothelial structure regulators, used for prevention of angoigenesis or cancer; gene therapy |
| 12/16/2004 | US20040253236 Glycoprotein VI and uses thereof |
| 12/16/2004 | US20040253232 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 12/16/2004 | US20040253231 monoclonal or polyclonal antibodies having specific reactivity with adenosine triphosphate binding domains, caspase recruitment domains and triosephosphate isomerase domain peptides, used for modulation of apoptosis |
| 12/16/2004 | US20040253222 transgenic neisseria having mutant phospholipase gene so that the bacteria has reduced phospholipase D activity as compared wild-type; polypeptide and polynucleotide, used for immunization of mammals against bacterial infections |
| 12/16/2004 | US20040253218 Method for reducing neuronal degeneration so as to ameliorate the effects of injury or disease |
| 12/16/2004 | US20040253215 Methods and compositions for treating disorders |
| 12/16/2004 | US20040253214 fusing cells; nucleic acid vector comprises a nucleotide sequence encoding a measles virus F glycoprotein and a nucleotide sequence encoding a chimeric measles virus H glycoprotein; nucleotide sequence encoding a syncytium-inducing polypeptide expressible on a eukaryotic cell surface |
| 12/16/2004 | US20040253210 replication-defective adenovirus type 7 that expresses one or more HIV polypeptides for use in stimulating an immune response to HIV-1; adenovirus serotype 7 cosmid vector; gene therapy |
| 12/16/2004 | US20040253178 Crystals and structures of spleen tyrosine kinase SYKKD |
| 12/16/2004 | DE10323081A1 Verwendung eines Polypeptides Use of a polypeptide |
| 12/16/2004 | CA2529061A1 Antimicrobial polypeptides |
| 12/16/2004 | CA2528851A1 Extracellular aspergillus polypeptides |
| 12/16/2004 | CA2528830A1 Transducible dna-binding proteins |
| 12/16/2004 | CA2528727A1 Immunomodulating compositions, uses therefor and processes for their production |
| 12/16/2004 | CA2528053A1 Phl p 5a derivatives having reduced allergenicity and retained t-cell reactivity |
| 12/16/2004 | CA2528046A1 Flavivirus replicon packaging system |
| 12/16/2004 | CA2527984A1 Vascular endothelial growth factor fusion constructs and uses thereof |
| 12/16/2004 | CA2527914A1 Improved secretion of neublastin |
| 12/16/2004 | CA2527721A1 Chimeric adenovirus capsid proteins |
| 12/16/2004 | CA2527346A1 Cell surface expression vector of sars virus antigen and microorganisms transformed thereby |
| 12/16/2004 | CA2527317A1 A library of phylogenetically related sequences |
| 12/16/2004 | CA2526365A1 Methods and compositions for amino acid production |
| 12/16/2004 | CA2524229A1 Canine ghrh gene, polypeptides and methods of use |
| 12/16/2004 | CA2518627A1 Method of screening antiobesity agents and animal model of obesity |
| 12/15/2004 | EP1486566A1 Proteins capable of binding to female sex hormones and process for producing the same |
| 12/15/2004 | EP1486565A1 Combination PDGF, KGF, IGF, and IGFBP for wound healing |
| 12/15/2004 | EP1486511A1 Refolding of polypeptides |
| 12/15/2004 | EP1486510A1 Transporter gene OATP- C |
| 12/15/2004 | EP1486509A2 Radiolabeled annexin-galactose cluster conjugates |
| 12/15/2004 | EP1486508A1 Use of the AL-1 neurotrophic factor, a ligand for an EPH-related tyrosine kinase receptor, for the preparation of a medicament for modulating angiogenesis associated disease or condition |
| 12/15/2004 | EP1486507A1 Transmembrane nfat inhibitory peptide |
| 12/15/2004 | EP1486506A1 Herpes simplex virus US11 protein and HIPK2 protein complexes and uses thereof |
| 12/15/2004 | EP1486505A1 Angiotensin derivatives |
| 12/15/2004 | EP1486214A1 Botulinum toxins for treating muscle spasm |
| 12/15/2004 | EP1485719A2 Peptide epitopes common to antigens of the same multigene family |
| 12/15/2004 | EP1485709A1 Therapeutic methods employing pai-1 inhibitors and transgenic non-human animal for screening candidate pai-1 inhibitors |
| 12/15/2004 | EP1485504A2 Novel hmga alleles and use of the same as genetic markers for growth, fatness, meat quality and feed efficiency traits |
| 12/15/2004 | EP1485497A2 Ricin vaccine and methods of making and using thereof |